8-Hydroxyquinolin-2(1H)-one analogues as potential β2-agonists: Design, synthesis and activity study

Eur J Med Chem. 2021 Nov 15:224:113697. doi: 10.1016/j.ejmech.2021.113697. Epub 2021 Jul 10.

Abstract

β2-Agonists that bind to plasmalemmal β2-adrenoceptors causing cAMP accumulation are widely used as bronchodilators in chronic respiratory diseases. Here, we designed and synthesized a group of 8-hydroxyquinolin-2(1H)-one analogues and studied their β2-agonistic activities with a cellular cAMP assay. Compounds B05 and C08 were identified as potent (EC50 < 20 pM) and selective β2-agonists among the compounds tested. They behaved as partial β2-agonists in non-overexpressed HEK293 cells, and possessed rapid smooth muscle relaxant actions and long duration of action in isolated guinea pig tracheal strip preparations. In summary, B05 and C08 are β2-agonists with potential applicability in chronic respiratory diseases.

Keywords: Asthma; COPD; Formoterol; Indacaterol; Olodaterol; β(2)-adrenoceptor agonist.

MeSH terms

  • Animals
  • Dose-Response Relationship, Drug
  • Drug Design*
  • Guinea Pigs
  • HEK293 Cells
  • Humans
  • Models, Molecular
  • Molecular Structure
  • Quinolines / chemical synthesis
  • Quinolines / chemistry
  • Quinolines / pharmacology*
  • Receptors, Adrenergic, beta-2 / metabolism*
  • Structure-Activity Relationship

Substances

  • 8-hydroxyquinolin-2(1H)-one
  • Quinolines
  • Receptors, Adrenergic, beta-2